Date Filed | Type | Description |
10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2023 |
4
| MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Paid exercise price by delivering 170 shares
@ $504.08, valued at
$85.7k
Exercised 384 restricted stock units
@ $0 |
|
07/17/2023 |
4
| MAZELSKY JONATHAN JAY (Director) has filed a Form 4 on DENTSPLY SIRONA Inc.
Txns:
| Granted 19 shares
@ $0 Granted 1 options to buy
@ $41.14, valued at
$36.9 |
|
06/29/2023 |
4
| MAZELSKY JONATHAN JAY (Director) has filed a Form 4 on DENTSPLY SIRONA Inc.
Txns:
| Granted 264 options to buy
@ $39.58, valued at
$10.4k
|
|
05/24/2023 |
3
| MAZELSKY JONATHAN JAY (Director) has filed a Form 3 on DENTSPLY SIRONA Inc. |
05/19/2023 |
4
| MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Gifted 602 shares
@ $0 |
|
05/05/2023 |
4
| MAZELSKY JONATHAN JAY (President and CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Exercised 560 options to buy
@ $178.26, valued at
$99.8k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2022 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Sold 972 shares
@ $433.3741, valued at
$421.2k
Sold 6,385 shares
@ $434.2615, valued at
$2.8M
Sold 2,543 shares
@ $435.0712, valued at
$1.1M
Sold 600 shares
@ $435.8775, valued at
$261.5k
Exercised 18,998 options to buy
@ $62, valued at
$1.2M
|
|
11/09/2022 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Sold 900 shares
@ $378.5951, valued at
$340.7k
Sold 2,000 shares
@ $379.4994, valued at
$759k
Sold 500 shares
@ $380.852, valued at
$190.4k
Sold 3,704 shares
@ $382.8057, valued at
$1.4M
Sold 2,716 shares
@ $383.2864, valued at
$1M
Sold 3,018 shares
@ $384.4651, valued at
$1.2M
Sold 392 shares
@ $385.0122, valued at
$150.9k
Exercised 24,002 options to buy
@ $52, valued at
$1.2M
|
|
08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2022 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Paid exercise price by delivering 1,423 shares
@ $505.53, valued at
$719.4k
Granted 22,366 options to buy
@ $505.53, valued at
$11.3M
Granted 12,557 options to buy
@ $556.083, valued at
$7M
Granted 197 options to buy
@ $505.53, valued at
$99.6k
Granted 3,833 restricted stock units
@ $0 Exercised 459 restricted stock units
@ $0 Exercised 505 restricted stock units
@ $0 Exercised 435 restricted stock units
@ $0 Exercised 974 restricted stock units
@ $0 Exercised 690 restricted stock units
@ $0 |
|
08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/09/2020 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Sold 355 shares
@ $463.4548, valued at
$164.5k
Sold 1,307 shares
@ $465.0234, valued at
$607.8k
Sold 107 shares
@ $465.8077, valued at
$49.8k
Sold 310 shares
@ $467.3319, valued at
$144.9k
Sold 400 shares
@ $468.9235, valued at
$187.6k
Sold 714 shares
@ $470.3444, valued at
$335.8k
Sold 264 shares
@ $471.3391, valued at
$124.4k
Sold 247 shares
@ $473.99, valued at
$117.1k
Sold 200 shares
@ $475.178, valued at
$95k
Sold 300 shares
@ $476.73, valued at
$143k
Sold 209 shares
@ $468.465, valued at
$97.9k
|
|
08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2020 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Sold 1,145 shares
@ $275.7245, valued at
$315.7k
Sold 1,337 shares
@ $276.7072, valued at
$370k
Sold 3,354 shares
@ $277.8769, valued at
$932k
Sold 1,676 shares
@ $279.0054, valued at
$467.6k
Sold 100 shares
@ $280.133, valued at
$28k
Sold 388 shares
@ $281.9705, valued at
$109.4k
Exercised 13,824 options to buy
@ $45.84, valued at
$633.7k
|
|
01/16/2020 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Exercised 2,188 options to buy
@ $45.84, valued at
$100.3k
|
|
11/05/2019 |
4
| MAZELSKY JONATHAN JAY (President & CEO) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Exercised 27,992 options to buy
@ $306.526, valued at
$8.6M
|
|
08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2018 |
4
| MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Paid exercise price by delivering 446 shares
@ $196.8, valued at
$87.8k
Exercised 961 restricted stock units
@ $0 |
|
02/16/2018 |
4
| MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Paid exercise price by delivering 778 shares
@ $178.26, valued at
$138.7k
Granted 25,140 options to buy
@ $178.26, valued at
$4.5M
Granted 560 options to buy
@ $178.26, valued at
$99.8k
Granted 2,524 restricted stock units
@ $0 Exercised 544 restricted stock units
@ $0 Exercised 403 restricted stock units
@ $0 Exercised 472 restricted stock units
@ $0 Exercised 737 restricted stock units
@ $0 Exercised 459 restricted stock units
@ $0 |
|
12/07/2017 |
4
| MAZELSKY JAY (Executive Vice President) has filed a Form 4 on IDEXX LABORATORIES INC /DE
Txns:
| Paid exercise price by delivering 471 shares
@ $159.78, valued at
$75.3k
Exercised 961 restricted stock units
@ $0 |
|
09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|